We are live on
!
Find out more
MCM
McKinley Capital Management Portfolio holdings
AUM
$571M
1-Year Est. Return
36.44%
This Fund
S&P 500
This Quarter
Est. Return
+4.84%
1 Year Est. Return
+36.44%
3 Year Est. Return
+63.3%
5 Year Est. Return
+224.69%
10 Year Est. Return
+867.52%
AUM
$1.99B
AUM Growth
–
Cap. Flow
+$1.97B
Cap. Flow
% of AUM
99.05%
Top 10 Holdings %
Top 10 Hldgs %
20.76%
Holding
340
New
340
Increased
–
Reduced
–
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$47.9M |
| 2 |
Visa
V
|
+$47M |
| 3 |
Biogen
BIIB
|
+$45.3M |
| 4 |
Cisco
CSCO
|
+$40.6M |
| 5 |
Credicorp
BAP
|
+$40.4M |
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 17.63% |
| 2 | Financials | 16.63% |
| 3 | Industrials | 11.97% |
| 4 | Technology | 11.89% |
| 5 | Healthcare | 10.95% |
Similar funds
GIM
PRC
PWS
SCM
IFAM
JWM
TWM
AT
McKinley Capital Management's Q2 2013 Portfolio in Review
Q2 2013 is the first quarter with a 13F filing on record for McKinley Capital Management, which disclosed 340 positions worth $1.99B. Its ten largest holdings account for 21% of the portfolio.
Its largest position is Gilead Sciences: 918,868 shares worth $47.1M.
By sector, the portfolio is most concentrated in Consumer Discretionary at 18% of assets, followed by Financials and Industrials.
- McKinley Capital Management's largest Q2 2013 buy was Gilead Sciences: 918,868 shares worth $47.1M.
- McKinley Capital Management's ten largest holdings make up 21% of its $1.99B portfolio in Q2 2013.
- McKinley Capital Management disclosed 340 positions in Q2 2013, its first 13F filing on record.
Based on McKinley Capital Management's 13F filing for Q2 2013, filed 9 Aug 2013.